Unlearn.ai is a company that utilizes AI technology to accelerate clinical drug development and eliminate trial and error in medicine. With the help of patient digital twins, Unlearn.ai simulates individual health outcomes and forecasts patient health over time. By comparing potential health outcomes and estimating treatment effects, the tool enables AI-powered clinical trials to reach full enrollment faster and prioritize patient-centric care.